Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Key drivers include: Increased FDA enforcement risk Narrower legal interpretations under the SAFE Drugs Act Reduced flexibility tied to drug shortages Direct enforcement by patent holders The possibility of injunctions that can halt operations overnight For many companies, the legal exposure now outweighs the potential revenue
Proper documentation, storage and handling practices help maintain sample integrity throughout research activities
In this report we demonstrate the efficacy of multiplexing the CellTox Green Cytotoxicity Assay with the GSH/GSSG-Glo Assay to determine both the cytotoxic and oxidative effects of compounds on cultured cells in a single assay plate
A 2024 study published in The BMJ reports a staggering 700% increase in the number of U.S
US$ 28.43
US$ 26.92
US$ 28.37
;Resize=(1280,712))
US$ 24.96
